Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) to Present Company Overview at Upcoming Conferences
5/10/2013 10:59:09 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Announces First Quarter 2013 Financial Results and Recent Corporate Developments
5/10/2013 10:29:09 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Initiates Dosing in Phase I Multiple Ascending Dose Study of Drug for Treatment of Marburg Virus
5/7/2013 10:29:50 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) to Announce First Quarter 2013 Financial Results and Corporate Update on May 9, 2013
4/30/2013 11:23:21 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) to Present Company Overview at the Needham Annual Healthcare Conference
4/22/2013 12:03:11 PM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Drops After FDA Asks for More Info
4/16/2013 7:03:20 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) and University of Western Australia Announce Exclusive Worldwide Licensing Agreement for Exon-Skipping Program in Duchenne Muscular Dystrophy
4/11/2013 11:09:01 AM
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy
4/5/2013 9:33:15 AM
More...
|
New-Look Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Eyes Approval for Muscular Dystrophy Drug
4/4/2013 7:51:40 AM
More...
|
Emerging Growth Equities, Ltd. Initiates Coverage of Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) (SRPT) With a BUY Rating and $38.00 Price Target
3/12/2013 9:49:26 AM
More...
|
|